Literature DB >> 24688106

Assessing the prognostic impact of immune cell infiltrates in follicular lymphoma.

Falko Fend1, Leticia Quintanilla-Martínez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24688106      PMCID： PMC3971067          DOI： 10.3324/haematol.2014.104968

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  25 in total

1.  Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma.

Authors:  Annuska M Glas; Laurent Knoops; Leonie Delahaye; Marie José Kersten; Robby E Kibbelaar; Lodewyk A Wessels; Ryan van Laar; J Han J M van Krieken; Joke W Baars; John Raemaekers; Philip M Kluin; Laura J van't Veer; Daphne de Jong
Journal:  J Clin Oncol       Date:  2007-01-02       Impact factor: 44.544

2.  Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols.

Authors:  Daphne de Jong; Ad Koster; Anton Hagenbeek; John Raemaekers; Dennis Veldhuizen; Sabien Heisterkamp; Jan Paul de Boer; Martine van Glabbeke
Journal:  Haematologica       Date:  2008-12-04       Impact factor: 9.941

3.  Distribution, function, and prognostic value of cytotoxic T lymphocytes in follicular lymphoma: a 3-D tissue-imaging study.

Authors:  Camille Laurent; Sabina Müller; Catherine Do; Talal Al-Saati; Sophie Allart; Luigi Maria Larocca; Stefan Hohaus; Sophie Duchez; Anne Quillet-Mary; Guy Laurent; Pierre Brousset; Salvatore Valitutti
Journal:  Blood       Date:  2011-08-19       Impact factor: 22.113

4.  The presence of STAT1-positive tumor-associated macrophages and their relation to outcome in patients with follicular lymphoma.

Authors:  Tomás Alvaro; Marylène Lejeune; Francisca I Camacho; Ma Teresa Salvadó; Lydia Sánchez; Juan F García; Carlos Lopez; Joaquín Jaén; Ramón Bosch; Lluis E Pons; Carmen Bellas; Miguel A Piris
Journal:  Haematologica       Date:  2006-12       Impact factor: 9.941

Review 5.  Pathology, pathogenesis and molecular genetics of follicular NHL.

Authors:  E Leich; G Ott; A Rosenwald
Journal:  Best Pract Res Clin Haematol       Date:  2011-04-07       Impact factor: 3.020

6.  Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL).

Authors:  Pedro Farinha; Hamid Masoudi; Brian F Skinnider; Karey Shumansky; John J Spinelli; Karamjit Gill; Richard Klasa; Nicolas Voss; Joseph M Connors; Randy D Gascoyne
Journal:  Blood       Date:  2005-06-02       Impact factor: 22.113

7.  Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome.

Authors:  Abigail M Lee; Andrew J Clear; Maria Calaminici; Andrew J Davies; Suzanne Jordan; Finlay MacDougall; Janet Matthews; Andrew J Norton; John G Gribben; T Andrew Lister; Lindsey K Goff
Journal:  J Clin Oncol       Date:  2006-10-10       Impact factor: 44.544

8.  Follicular lymphoma cells induce changes in T-cell gene expression and function: potential impact on survival and risk of transformation.

Authors:  Shahryar Kiaii; Andrew J Clear; Alan G Ramsay; Derek Davies; Ajanthah Sangaralingam; Abigail Lee; Maria Calaminici; Donna S Neuberg; John G Gribben
Journal:  J Clin Oncol       Date:  2013-06-17       Impact factor: 44.544

9.  Follicular lymphoma international prognostic index.

Authors:  Philippe Solal-Céligny; Pascal Roy; Philippe Colombat; Josephine White; Jim O Armitage; Reyes Arranz-Saez; Wing Y Au; Monica Bellei; Pauline Brice; Dolores Caballero; Bertrand Coiffier; Eulogio Conde-Garcia; Chantal Doyen; Massimo Federico; Richard I Fisher; Javier F Garcia-Conde; Cesare Guglielmi; Anton Hagenbeek; Corinne Haïoun; Michael LeBlanc; Andrew T Lister; Armando Lopez-Guillermo; Peter McLaughlin; Noël Milpied; Pierre Morel; Nicolas Mounier; Stephen J Proctor; Ama Rohatiner; Paul Smith; Pierre Soubeyran; Hervé Tilly; Umberto Vitolo; Pier-Luigi Zinzani; Emanuele Zucca; Emili Montserrat
Journal:  Blood       Date:  2004-05-04       Impact factor: 22.113

10.  A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone.

Authors:  Minna Taskinen; Marja-Liisa Karjalainen-Lindsberg; Heidi Nyman; Leena-Maija Eerola; Sirpa Leppä
Journal:  Clin Cancer Res       Date:  2007-10-01       Impact factor: 12.531
View more
  4 in total

Review 1.  The emerging role of immune checkpoint inhibition in malignant lymphoma.

Authors:  Ida Hude; Stephanie Sasse; Andreas Engert; Paul J Bröckelmann
Journal:  Haematologica       Date:  2016-11-24       Impact factor: 9.941

2.  MicroRNA signatures and Foxp3+ cell count correlate with relapse occurrence in follicular lymphoma.

Authors:  Giorgio Malpeli; Stefano Barbi; Corinna Greco; Simonetta Zupo; Anna Bertolaso; Maria Teresa Scupoli; Mauro Krampera; Paul Takam Kamga; Carlo Maria Croce; Aldo Scarpa; Alberto Zamò
Journal:  Oncotarget       Date:  2018-04-13

3.  Comparative analysis of post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation reveals differences in the tumor microenvironment.

Authors:  Mathis Overkamp; Massimo Granai; Irina Bonzheim; Julia Steinhilber; Jens Schittenhelm; Wolfgang Bethge; Leticia Quintanilla-Martinez; Falko Fend; Birgit Federmann
Journal:  Virchows Arch       Date:  2020-12-15       Impact factor: 4.064

4.  The Expression of CD9 and PIK3CD is Associated with Prognosis of Follicular Lymphoma.

Authors:  Tieying Dong; Zhaoliang Liu; Shu Zhao; Chengyi Hu; Yupeng Liu; WenJie Ma; Qingyuan Zhang
Journal:  J Cancer       Date:  2015-10-15       Impact factor: 4.207
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.